[
  {
    "id": "D001",
    "mta": true,
    "projects": [
      "PRG001"
    ],
    "studies": [
      "STD001"
    ],
    "clinical_data": {
      "enrollment_date": "2024-06-14",
      "enrollment_age": 46,
      "sex": "Female",
      "diagnosis": "Glioblastoma",
      "primary_site": "Brain",
      "localization": "Left",
      "vital_status": true,
      "vital_status_change_date": null,
      "vital_status_change_day": null,
      "progression_status": false,
      "progression_status_change_date": null,
      "progression_status_change_day": null,
      "steroids_reactive": true,
      "kps": 90
    },
    "treatments": [
      {
        "therapy": "Surgery",
        "details": "Left frontal lobe tumor; gross total resection; no complications.",
        "start_date": "2024-06-18",
        "start_day": null,
        "end_date": "2024-06-18",
        "duration_days": null,
        "results": "Post-op MRI indicates near-total resection."
      },
      {
        "therapy": "Temozolomide",
        "details": "Stupp protocol: 5/28-day cycles, total of 6 cycles.",
        "start_date": "2024-07-15",
        "start_day": null,
        "end_date": "2024-12-01",
        "duration_days": null,
        "results": "No evidence of progression at 6 months."
      }
    ]
  },
  {
    "id": "D002",
    "mta": true,
    "projects": [
      "PRG001"
    ],
    "studies": [
      "STD001"
    ],
    "clinical_data": {
      "enrollment_date": "2022-05-20",
      "enrollment_age": 74,
      "sex": "Female",
      "diagnosis": "Glioblastoma",
      "primary_site": "Brain",
      "localization": "Right",
      "vital_status": false,
      "vital_status_change_date": "2023-01-15",
      "vital_status_change_day": null,
      "progression_status": true,
      "progression_status_change_date": "2022-10-01",
      "progression_status_change_day": null,
      "steroids_reactive": false,
      "kps": 50
    },
    "treatments": [
      {
        "therapy": "Chemoradiation",
        "details": "Hypofractionated RT (40 Gy/15 fx) with temozolomide due to poor performance status.",
        "start_date": "2022-05-30",
        "start_day": null,
        "end_date": "2022-06-20",
        "duration_days": null,
        "results": "Initial disease control; early progression noted."
      }
    ]
  },
  {
    "id": "D003",
    "mta": true,
    "projects": [
      "PRG001"
    ],
    "studies": [
      "STD001"
    ],
    "clinical_data": {
      "enrollment_date": "2022-09-03",
      "enrollment_age": 47,
      "sex": "Male",
      "diagnosis": "Glioblastoma",
      "primary_site": "Brain",
      "localization": "Left",
      "vital_status": true,
      "vital_status_change_date": null,
      "vital_status_change_day": null,
      "progression_status": false,
      "progression_status_change_date": null,
      "progression_status_change_day": null,
      "steroids_reactive": true,
      "kps": 90
    },
    "treatments": [
      {
        "therapy": "Surgery",
        "details": "Left temporal lobe; subtotal resection due to proximity to eloquent cortex.",
        "start_date": "2022-09-06",
        "start_day": null,
        "end_date": "2022-09-06",
        "duration_days": null,
        "results": "Residual tumor noted on post-op MRI."
      },
      {
        "therapy": "Temozolomide",
        "details": "6 cycles adjuvant TMZ per Stupp protocol.",
        "start_date": "2022-10-03",
        "start_day": null,
        "end_date": "2023-03-20",
        "duration_days": null,
        "results": "Stable disease through adjuvant therapy."
      }
    ]
  },
  {
    "id": "D004",
    "mta": true,
    "projects": [
      "PRG001"
    ],
    "studies": [
      "STD001"
    ],
    "clinical_data": {
      "sex": "Male",
      "enrollment_date": "2021-11-05",
      "enrollment_age": 76,
      "diagnosis": "Glioblastoma",
      "primary_site": "Brain",
      "localization": "Right",
      "vital_status": false,
      "vital_status_change_date": "2022-07-12",
      "vital_status_change_day": null,
      "progression_status": true,
      "progression_status_change_date": "2022-02-10",
      "progression_status_change_day": null,
      "steroids_reactive": false,
      "kps": 50
    },
    "treatments": [
      {
        "therapy": "Chemoradiation",
        "details": "Standard RT (60 Gy/30 fx) with temozolomide; treatment interrupted twice due to fatigue.",
        "start_date": "2021-11-15",
        "start_day": null,
        "end_date": "2021-12-27",
        "duration_days": null,
        "results": "Partial response; progression within months."
      }
    ]
  }
]